跳至主要内容
临床试验/NL-OMON41959
NL-OMON41959已完成不适用

Towards optimal personalized diet and vitamin supplementation in patients with a neuroendocrine tumor; a pilot study - DIVIT-pilot

niversitair Medisch Centrum Groningen0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Adult NET patients (aged >= 18 years of age), with serotonine producing or non-serotonin producing tumors, with any tumor site and disease stage.
  • Use of somatostatin analogue for > 6 months.
  • Ability to comprehend Dutch (both reading and writing).
  • Written informed consent provided.

排除标准

  • Estimated life expectancy less than 3 months.
  • Patients who have a history of another primary malignancy, except for radical and adequately treated malignancies from which the patient has been disease free for >= 3 years. •
  • Major abdominal surgery during study period.
  • Known hypersensitivity of (components of) somatostatin analogue.

研究者

相似试验